Abatacept With Methotrexate- Phase IIB
Public ClinicalTrials.gov record NCT00162266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Two Different Doses of BMS-188667 Administered Intravenously to Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was conducted to assess the safety and tolerability of Abatacept combined with Methotrexate in participants with active rheumatoid arthritis (RA). The secondary objectives were to assess efficacy, pharmacodynamic marker activity, and immunogenicity of Abatacept combined with Methotrexate.
Study identification
- NCT ID
- NCT00162266
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 524 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2000 (Type not available)
- Primary completion
- Sep 2009 (Actual)
- Completion
- Sep 2009 (Actual)
- Last update posted
- Jun 1, 2012
2000 – 2009
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Huntsville | Alabama | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Highlands Ranch | Colorado | — | — |
| Local Institution | Largo | Florida | — | — |
| Local Institution | Titusville | Florida | — | — |
| Local Institution | West Palm Beach | Florida | — | — |
| Local Institution | Rome | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Wichita | Kansas | — | — |
| Local Institution | Cumberland | Maryland | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Worcester | Massachusetts | — | — |
| Local Institution | Duluth | Minnesota | — | — |
| Local Institution | Lincoln | Nebraska | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | Los Alamos | New Mexico | — | — |
| Local Institution | Albany | New York | — | — |
| Local Institution | Binghamton | New York | — | — |
| Local Institution | The Bronx | New York | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Duncansville | Pennsylvania | — | — |
| Local Institution | Sellersville | Pennsylvania | — | — |
| Local Institution | Amarillo | Texas | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00162266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00162266 live on ClinicalTrials.gov.